Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.

Screen shot from the Vaccination Game, including text explaining the virtual vaccine © Hal Drakesmith

The Vaccination Game, created by researchers at the MRC Weatherall Institute of Molecular Medicine (WIMM), in collaboration with Goldsmiths, University of London, challenges players to figure out how they can deploy limited doses of the vaccine to best control a disease modelled on influenza.

The idea of developing a game was conceived by Professor Hal Drakesmith and colleagues who are part of a research network focussing on immunising babies and mothers to fight infections in low and middle-income countries. Following funding from, and in collaboration with the IMPRINT research network, they were able to begin development of the game.

The full story is available on the MRC Weatherall Institute of Molecular Medicine website

The story is also featured on the University of Oxford website

Play the Vaccination Game

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.